Emergency department-administered, high-dose buprenorphine may enhance opioid use disorder treatment outcomes
July 15, 2021
High-dose buprenorphine therapy, provided under emergency department care, is safe and well tolerated in people with opioid use disorder experiencing opioid withdrawal symptoms, according to a study supported by the National Institutes of Health’s National Institute on Drug Abuse (NIDA) through the Helping to End Addiction Long-term Initiative, or the NIH HEAL Initiative.Read the press release
Emotional Well-Being and the Power of Connections to Fight the Opioid Epidemic
Read in-depth stories about research projects supported by the initiative.